Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID05337722

A Smartphone Intervention for Pregnancy Smoking Cessation With Peer Support

Led by Michigan State University · Updated on 2026-01-16

790

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

Sponsors

M

Michigan State University

Lead Sponsor

B

Babes-Bolyai University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a smartphone-based intervention designed to help pregnant smokers quit smoking by using an app combined with peer support. The project aims to develop, implement, and test the feasibility and effectiveness of the SFT 2.0 app, which uses deep tailoring, reinforcement learning, and motivational interviewing counseling techniques. The study also seeks to build mobile health research capacity in Romania and improve support for smoking cessation during pregnancy and postpartum periods. The trial has three study groups: one group uses the SFT 2.0 app and receives a fixed number of four counseling video sessions during pregnancy up to one month postpartum; another group uses an adaptive version of the app with as-needed counseling sessions ranging from one to ten during the same period; and a control group receives low-dose counseling with one prenatal and one postnatal session. Both experimental groups involve use of the app by pregnant smokers and their nominated support persons. Participants will be involved for a period covering pregnancy through postpartum, with evaluations of smoking cessation and abstinence conducted at three and six months after birth. Researchers will assess outcomes such as reach, adoption, implementation, and user engagement one month after birth. The trial is randomized and double-blinded, with assessments including video counseling and app usage data to measure effectiveness and feasibility of the intervention.

CONDITIONS

Brief Title

App for Pregnancy Smoking Cessation With Peer Support

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 or older
  • Currently pregnant
  • Regular user of cigarettes
  • Has an Android phone with broadband data access
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Outpatient Treatment

Duration - From enrollment through 1 month postpartum

Participants use the SFT 2.0 smoking cessation app and receive motivational interviewing counseling through video sessions during pregnancy and up to 1 month postpartum.

Between 1 and 10 video counseling sessions depending on group assignment

Trial Site Locations

Total: 1 location

1

Babes-Bolyai University

Cluj-Napoca, Cluj, Romania, 400301

Actively Recruiting

Loading map...

Research Team

C

Cristian I Meghea, PhD

O

Oana M Blaga

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Similar Trials

Identifying Barriers and Facilitators to Participation in mH...

Smoking Cessation

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Smartphone intervention for pregnancy smoking cessation with peer support: the study protocol of the SmokeFree Together 2.0 (SFT 2.0) randomised controlled trial.

Oana M Blaga, Marina D Dascal, Alexandra Onișor...

https://pubmed.ncbi.nlm.nih.gov/40132847